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Hyperparathyroidism (HPT) was identified concurrently in
Europe and United States in the mid 1920s.1 The illness
was first described in the setting of severe bone disease
resulting in significant morbidity.2 HPT is divided into pri-
mary, secondary and tertiary categories. Primary HPT
occurs in the setting of excessive parathyroid hormone
(PTH) secretion by an autonomous gland resulting in hyper-
calcemia. Secondary HPT occurs in the setting of hypocalca-
emia or vitamin D deficiency acting as a stimulus for PTH
production. Tertiary HPT is associated with renal failure
and results from autonomous functioning glands in patients741-9409/$ - see front matter c 2005 Elsevier Ltd. All rights reserved
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E-mail address: rsgomez@ufmg.br (R.S. Gomez).with long-standing secondary HPT.2 The fourth type of HPT
occurs due to ectopic HPT, which is thought to arise from
increased parathyroid hormone levels synthesized in pa-
tients with malignant diseases.3,4 Secondary HPT most com-
monly occurs in patients with chronic renal failure caused
by decreased levels of 1,25-dihydroxy vitamin D.2 We report
unusual case of peripheral brown tumour in the maxilla as
manifestation of secondary HPT associated with chronic
renal failure.Case report
A 53-year-old man was referred to the Oral Medicine Service
at the Dentistry School, Universidade Federal de Minas Ger-
ais, in November 2004 for evaluation of an oral lesion. Med-
ical history was significant for chronic progressive renal
failure. Physical extra oral examination was unremarkable.
Figure 1 (A) Clinical appearance of the lesion, (B) Radio-
graphic view depicting superficial erosion of the bone in the
region of the teeth 22,23 and 24 and (C) High microscopic
viewshowing proliferation of mononuclear ovoid and spindle
shaped cells and multinucleated giant cells (HE, original
magnification ·400).
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examination showed a violet, painless, sessile swelling on
the anterior region of the maxilla measuring 35 · 15 ·
10 mm (Fig. 1A). The patient reported that the lesion had
appeared 8 months before. Radiographic exam showed
superficial erosion of the bone in the region of the teeth
22, 23 and 24 (Fig. 1B). The lesion was surgically removed
and the histopathological analysis revealed a network of
ovoid to spindle-shaped mesenchymal cells with focal
aggregates of multinucleated giant cells diffusely present
throughout the lesion (Fig. 1C).
Blood analysis demonstrated PTH level of 223.0 pg/ml
(normal range: 2–72 pg/ml). Calcium, phosphorus and alka-
line phosphatase levels were within normal limits. A diagno-
sis of brown tumour associated to a secondary HPT was
made. The patient had no familiar history of HPT or otherendocrine disorder and he has been prepared to be submit-
ted to kidney transplant.
Discussion
Bone involvement is the late manifestation of HPT.3 Classic
skeletal lesions, which are bone resorption, bone cysts,
brown tumours and generalized osteopenia, occur in less
than 5% of cases.5 The ribs, clavicles, pelvic girdle, and
the mandible are the most often involved bones.6,7 Both pri-
mary and secondary HPT are prone to cause loss of the lam-
ina dura.8–10
Brown tumours are non-neoplastic lesions resulting from
abnormal bone metabolism in HPT.11 It represents the ter-
minal stage of the bone remodelling process during second-
ary HPT.7 The committed sites are facial bones, clavicle,
ribs, pelvis, and/or femur.12 In contrast to secondary HPT,
jaw bones are commonly affected by brown tumours in
primary HPT.13 Oral radiographic manifestations of HPT
include a generalized loss of lamina dura surrounding the
roots of the teeth, loss of cortication around the inferior
alveolar canal and maxillary sinus, and of the trabecular
pattern of the jaws.14 Peripheral manifestation of brown tu-
mour on the oral cavity is rare. As it can be observed in the
present case, the clinical appearance simulates peripheral
giant cell granuloma.
The term brown tumour comes from the colour of lesion,
which results from the vascularity, haemorrhage and depos-
its of hemosiderin.15 Therefore, the brown tumour is actu-
ally a kind of giant cell lesion and often appears as a
multiple and expansive osteolytic lesion of the bone. Be-
cause it is difficult to distinguish histopathologically brown
tumour from other giant cell lesions, a clinical diagnosis is
made based on the association with HPT.16 Histologically,
all giant cell lesions have two main components: mononu-
clear stromal cells and multinucleated giant cells.
There is no single test that establishes the diagnosis of
secondary HPT. However, the diagnosis is made based on
the high level of PTH associated with low or normal serum
calcium.2 In the present case the patient presented chronic
progressive renal failure together with PTH level five times
higher than normal and did not show alteration in calcium
level.
The treatment for brown tumour in the jaws includes
enucleation and curettage,17 radical resection and recon-
struction, radiation therapy, and chemotherapy.18 Surgical
excision of the brown tumours is indicated for large and dis-
figuring lesions and in case that the affected bone is weak-
ened.19 However, other authors initially treat this lesion
with systemic corticosteroids and, when it reduces its size,
they make its surgical excision.20 In conclusion, the present
report describes a rare case of peripheral brown tumour
associated with secondary HPT simulating a peripheral giant
cell lesion of the jaws. The lesion was surgically treated.Acknowledgements
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